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Intentional and accidental poisoning or overdose is a
serious concern in Iran. There are some reasons for this,
first of which, is that Iran has the highest rate of opium
addiction in the world. Also, there are no efficient rules
and enough surveillance on selling the pharmaceutical
drugs in the pharmacies in Iran and nearly all medica-
tions are available to the lay people as over the counter
medications. So, there are so many poisoned patients ad-
mitted to the Iranian hospitals every year.
Treatment of the poisoned patients in Iran has been
growing within the recent decades and there are some
referral poison hospitals in each part of Iran. Although
in many countries these patients refer to general hospi-
tals and are managed by general or emergency medicine
physicians under the supervision of the clinical toxicolo-
gists, in Iran the patients' falimies prefer to bring them
to the tertiary poison hospitals and the physicians prefer
to refer them to these centers because of the legal prob-
lems they generally encounter while managing these
patients [1]. In Tehran, the capital city of Iran with a
population of around 8,000,000, there are two referral
poison hospitals: Loghman-Hakim poison hospital and
Baharloo poison hospital. Loghman-Hakim Poison Hos-
pital is the biggest tertiary poisoning hospital in Tehran
and probably in the Iran and the middle east. This hos-
pital gives the needed inpatient care to almost 100 poi-
soned patients a day. Other hospitals skilled in the
management of the poisoned patients are Imam Reza
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and Ali-Asghar hospitals in Shiraz. Moreover, poisoning
management centers in Birjand, Arak, Ghom, Ardabil,
Tabriz, Sari, Bandar Abbas and Rasht are developing [2].
Every day, there are lots of requests from the ex-
tremely ill poisoned patients being in the long queue to
be admitted to these centers from general hospitals.
However, even with the 24-hour efforts of the medical
and paramedical staff of these centers, it is not possible
to respond to all of these requests mainly due to the lim-
itations in the hospital beds. This is while the staff in
emergency departments (EDs) of these centers generally
have to admit the patients referring to them at the first
step (including those who can out-patiently be managed)
to their wards to overcome the overcrowdedness of
their EDs.
On the other hand, the matter of outpatient treatment
of the poisoned patients is a known entity worldwide
that has been suggested to be safe and effective in many
cases of poisoning even with ethanol, opioid, and carbon
monoxide [3-13]. In special settings of these poisonings,
a supervising toxicologist monitors the patients with
mild to moderate intoxications for a median period of
3.8 hours until the patient is ready for discharge [14].
This may reduce the number of the patients who are ad-
mitted to the wards while they can be monitored for
about 6–8 hours and then be discharged (for instance an
asympthomatic TCA-poisoned patient). In the current
setting, these patients are generally admitted to the
wards because there is not enough space for them to be
monitored in the emergency department. These patients
have to be hospitalized and pay the cost of at least one
night hospital stay without it being really necessary while
taking the place of other critically ill patients. It can,
therefore, be suggested that by allocating 10 or maybe
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admission of more poisoned patients in desperate need
of advanced specialized and even critical care. Even, the
psychiatry consultation routinely offered to the patients
may be given in the same setting. This approach how-
ever is not applicable to the patients with baseline psy-
chiatric disorders. This way, both the patients’ costs and
emergency room overcrowding will be decreased while
more critically ill patients can benefit from the care
given by experienced medical staff with their specific tal-
ent to be managing poisoned patients.
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